Bamco Inc Maxcyte, Inc. Transaction History

Bamco Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.03 - $5.89 $786,164 - $1.15 Million	-195,078 Reduced 8.94%	1,987,904 $9.84 Million
Q4 2022 Feb 14, 2023	SELL	$4.92 - $7.4 $418,037 - $628,755	-84,967 Reduced 3.75%	2,182,982 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $556,904 - $802,090	-123,209 Reduced 5.15%	2,267,949 $14.7 Million
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $7.92 Million - $15 Million	-2,207,511 Reduced 48.0%	2,391,158 $11.3 Million
Q1 2022 May 13, 2022	SELL	$5.26 - $10.84 $2.45 Million - $5.06 Million	-466,502 Reduced 9.21%	4,598,669 $32.1 Million

Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $31.2 Million - $45.6 Million	3,521,537 Added 228.13%	5,065,171 $51.6 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $18.8 Million - $26.6 Million	1,543,634 New	1,543,634 $18.8 Million

126

62M

2.4K

2.1K

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $412M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.